172 related articles for article (PubMed ID: 12719697)
1. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
Tartaglia A; Bianchini S; Vezzadini P
Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
Vezzadini C; Poggioli R; Casoni I; Vezzadini P
Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
4. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
6. Biochemical diagnosis of neuroendocrine GEP tumor.
Oberg K
Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
[TBL] [Abstract][Full Text] [Related]
7. The gastroenteropancreatic endocrine system and related tumors.
Solcia E; Capella C; Fiocca R; Cornaggia M; Bosi F
Gastroenterol Clin North Am; 1989 Dec; 18(4):671-93. PubMed ID: 2575601
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of the gastrointestinal tract. 1: Clinical aspects].
Müller MK; Niederle N; Singer MV
Fortschr Med; 1992 Jan; 110(3):50, 53-4. PubMed ID: 1607137
[TBL] [Abstract][Full Text] [Related]
9. [Endoscopic diagnosis of gastroenteropancreatic neuroendocrine tumors].
López-Jamar JM
Endocrinol Nutr; 2009 Sep; 56 Suppl 3():8-13. PubMed ID: 20542214
[TBL] [Abstract][Full Text] [Related]
10. 7B2, a possible marker for nonfunctioning pancreatic islet cell tumor.
Iguchi H; Yasuda D; Yamada Y; Funakoshi A; Wakasugi H; Bloom SR; Chretien M
Horm Metab Res; 1991 Oct; 23(10):486-9. PubMed ID: 1662184
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
12. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
Singh S; Law C
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
[TBL] [Abstract][Full Text] [Related]
14. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
15. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors.
Adrian TE; Uttenthal LO; Williams SJ; Bloom SR
N Engl J Med; 1986 Jul; 315(5):287-91. PubMed ID: 3014338
[TBL] [Abstract][Full Text] [Related]
16. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy.
Baudin E
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):228-39. PubMed ID: 17315031
[TBL] [Abstract][Full Text] [Related]
18. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
19. Approach to hepatic involvement by endocrine tumors of the gastrointestinal tract.
Stockmann F; Creutzfeldt W
Semin Liver Dis; 1988 Aug; 8(3):254-62. PubMed ID: 2906761
[TBL] [Abstract][Full Text] [Related]
20. [Pancreatic endocrine tumors].
Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
